Is Amgen Still a Top Dividend Stock?
The relationship between interest rates and dividend stocks tends to follow a predictable pattern. When the Federal Reserve signals a shift toward monetary easing, investors often rotate toward stable, high-yielding equities that can provide both income and potential appreciation.
(NASDAQ: AMGN) offers an intriguing test case for this dynamic heading into 2025. The biotech-giant's shares have slumped 3.37% in 2024, while the S 500 has surged 26.8% as of this writing, creating what might be a compelling entry point ahead of what could prove to be a long-winded rate-cutting cycle.
Image source: Getty Images.
Source Fool.com
Amgen Inc. Aktie
357,85 €
-0,98 %
Amgen Inc. wird von der Community favorisiert: Deutlich mehr Buy- als Sell-Einschätzungen.
Trotz eines niedrigeren Kursziels von 340 € für Amgen Inc. als der aktuelle Kurs von 357.85 €, zeigt sich ein negatives Potenzial von -4.99%.
